Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zurzuvae
Pharma
Supernus-Indivior merger is about scale, business development
Supernus and Indivior have agreed to a merger, forming a new CNS-focused biopharma, which will generate an expected $2.2B in sales this year.
Kevin Dunleavy
Aug 3, 2026 11:20am
With highest quarterly sales since '21, Biogen reverses guidance
Jul 29, 2026 11:05am
Lilly's Kisunla, Gilead's PrEP drug Yeytuo gain CHMP nods
Jul 25, 2025 11:03am
Sage lays off entire staff of 338 amid Supernus acquisition
Jun 30, 2025 10:46am
Beleaguered Sage bought for $561M
Jun 16, 2025 11:52am
As new launches take flight, 'a new Biogen' emerges, CEO says
May 1, 2025 11:55am
